Page last updated: 2024-10-31

mitoxantrone and DDPAC

mitoxantrone has been researched along with DDPAC in 1 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Brown, DG1
Shorter, J1
Wobst, HJ1

Reviews

1 review available for mitoxantrone and DDPAC

ArticleYear
Emerging small-molecule therapeutic approaches for amyotrophic lateral sclerosis and frontotemporal dementia.
    Bioorganic & medicinal chemistry letters, 2020, 02-15, Volume: 30, Issue:4

    Topics: Amyotrophic Lateral Sclerosis; Autophagy; C9orf72 Protein; DNA-Binding Proteins; Frontotemporal Deme

2020